BioSpace News Archive

Recommendations are detailed in new roadmaps (algorithms) outlining therapies and medications to help achieve optimal diabetes control and improved quality of life

Superfoods are a new revolution in nutrition.

Vizient, Inc. today announced Moving Analytics as the winner of its 2018 Innovation Challenge, an interactive competition between four early-stage growth health care companies.

KRY is the first in the world to offer a new treatment method for stage fright and fear of public speaking. The new treatment method strengthens KRY’s position as innovative industry leaders.

European Medicines Agency Will Evaluate LentiGlobin Marketing Authorization Application Under Accelerated Assessment

Promethera Biosciences SA today announced that Mutsuki Takano, currently Branch General Manager of Promethera Biosciences Japan Branch and Member of the Management Team of Promethera Biosciences SA will succeed Frank Hazevoets as Group Chief Financial Officer (Group CFO), in addition to his current responsibilities.

System Provides Real-Time Endoscopic Visible and Near-Infrared Fluorescence Imaging

BerGenBio ASA announces that the first patient has been dosed in the second stage of the phase II trial (BGBC008) evaluating the Company’s selective AXL inhibitor bemcentinib in combination with MSD’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in patients with previously treated advanced adenocarcinoma of the lung (non-small cell lung cancer, NSCLC) whose disease is progressing.

Alligator Bioscience AB today announced that they will receive a 500 000 SEK grant from Sweden’s government agency for innovation, Vinnova, for the project ‘Verification of the unique functionality of ATOR-1017 by 3D structure determination’.

Teva Pharmaceutical Industries Ltd. announced today that it will release its third quarter 2018 financial results on Thursday, November 1, 2018 at 7:00 a.m. ET.